Evidence map›Paper›PMID 20660628›Full record

ArticleThe Journal of cell biology2010

DNA damage signaling in response to double-strand breaks during mitosis.

Simona Giunta, Rimma Belotserkovskaya, Stephen P Jackson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 193 papers.

0numbers the graph read from it
0cells of the map it votes in
193citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

193 citing papers in PubMed, 311 citations in OpenAlex.

  1. Article
  2. Article
  3. Micronuclei: origins, assays, mechanisms, diseases and treatments.Signal transduction and targeted therapy · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Engineering Chromosome Bridges Through CRISPR/Cas9 to Decipher the Impact of Intercentromeric Distance on Resolution Dynamics.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

133 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Simona GiuntaWellcome Trust and Cancer Research UK Gurdon Institute, University of Cambridge, CB2 1QN Cambridge, England, UK.
Rimma Belotserkovskaya
Stephen P Jackson
Wellcome/Cancer Research UK Gurdon Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/D526 129Cancer Research UK 11224Cancer Research UK A5290Wellcome Trust
6 · The paper itself

Abstract

The signaling cascade initiated in response to DNA double-strand breaks (DSBs) has been extensively investigated in interphase cells. Here, we show that mitotic cells treated with DSB-inducing agents activate a "primary" DNA damage response (DDR) comprised of early signaling events, including activation of the protein kinases ataxia telangiectasia mutated (ATM) and DNA-dependent protein kinase (DNA-PK), histone H2AX phosphorylation together with recruitment of mediator of DNA damage checkpoint 1 (MDC1), and the Mre11-Rad50-Nbs1 (MRN) complex to damage sites. However, mitotic cells display no detectable recruitment of the E3 ubiquitin ligases RNF8 and RNF168, or accumulation of 53BP1 and BRCA1, at DSB sites. Accordingly, we found that DNA-damage signaling is attenuated in mitotic cells, with full DDR activation only ensuing when a DSB-containing mitotic cell enters G1. Finally, we present data suggesting that induction of a primary DDR in mitosis is important because transient inactivation of ATM and DNA-PK renders mitotic cells hypersensitive to DSB-inducing agents.

Indexed as

DNA Breaks, Double-StrandedDNA DamageAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell LineDNA-Activated Protein KinaseDNA-Binding ProteinsDNA RepairHistonesHumansIntracellular Signaling Peptides and ProteinsMitosisNuclear ProteinsProtein Serine-Threonine KinasesRecombinant Fusion ProteinsAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Activated Protein KinaseDNA-Binding ProteinsH2AX protein, humanHistonesIntracellular Signaling Peptides and ProteinsMDC1 protein, humanNuclear ProteinsPRKDC protein, humanProtein Serine-Threonine KinasesRecombinant Fusion ProteinsRNF168 protein, humanRNF8 protein, humanTP53BP1 protein, humanTrans-ActivatorsTumor Suppressor p53-Binding Protein 1Tumor Suppressor ProteinsUbiquitin-Protein Ligases

Identifiers

PMID20660628
PMCPMC2930281
OpenAlexW2120943086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.